ロード中...
MET Receptor Tyrosine Kinase
MET receptor tyrosine kinase (RTK) and its ligand hepatocyte growth factor (HGF) have become important therapeutic target in oncology, especially lung cancer. MET RTK is involved in cancer cell growth/survival, motility/migration, invasion/metastasis, and in angiogenesis. MET can be overexpressed in...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2009
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2846396/ https://ncbi.nlm.nih.gov/pubmed/19861919 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/01.JTO.0000361752.86918.09 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|